Kyowa Kirin (TKS: 4151)

Kyowa Kirin is a corporation based in Tokyo, Japan. Established in 1949, the company is a pharmaceutical and biotechnology company under Kirin Holdings. It contributes to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies. The assets of the company are managed by the board of directors.